Two studies could lead to new personalized therapies for lung cancer patients
Thursday, September 13, 2012 - 13:10
in Health & Medicine
Lung cancer is a leading cause of death worldwide and is associated with very low survival rates. Two new genome-sequencing studies have uncovered novel genes involved in the deadly disease, as well as striking differences in mutations found in patients with and without a history of smoking. The findings could pave the way for personalized therapies that boost survival rates.